Publications
- New-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity2022 | First Faculty of Medicine
- Targeting of the Mitochondrial TET1 Protein by Pyrrolo[3,2-b]pyrrole Chelators2022 | First Faculty of Medicine
- Strategy for improved therapeutic efficiency of curcumin in the treatment of gastric cancer2019 | First Faculty of Medicine
- Epigenetic agents in combined anticancer therapy2018 | First Faculty of Medicine
- Supramolecular Approach in Photodynamic and Photothermal Therapies2017 | First Faculty of Medicine
- Preparation of Tryptanthrin Derivates Bearing a Thiosemicarbazone Moiety to Inhibit SARS-CoV-2 Replication2023 | First Faculty of Medicine
- Therapeutic potential and limitations of curcumin as antimetastatic agent2023 | First Faculty of Medicine
- TET protein inhibitors: Potential and limitations2023 | First Faculty of Medicine
- Combination of quinoxaline with pentamethinium system: Mitochondrial staining and targeting2023 | First Faculty of Medicine
- Chelators as Antineuroblastomas Agents2023 | First Faculty of Medicine
Loading network view...